Bill

Bill > S4866


US S4866

US S4866
Sickle Cell Disease Treatment Centers Act of 2022


summary

Introduced
09/15/2022
In Committee
09/15/2022
Crossed Over
Passed
Dead
01/03/2023

Introduced Session

117th Congress

Bill Summary

A bill to establish a program to address sickle cell disease and other heritable hemoglobinopathies.

AI Summary

This bill establishes a program to address sickle cell disease and other heritable hemoglobinopathies. It does this by creating "Sickle Cell Disease Treatment Centers" that use a "hub-and-spoke" framework to promote access to coordinated, longitudinal healthcare for sickle cell disease patients. The bill provides grants to eligible entities, which are sickle cell disease treatment hub-and-spoke networks that include a medical hub (a hospital, clinic, or university health center) and at least one spoke (a Federally-qualified health center or other healthcare provider) working in partnership with a community-based organization. The centers will provide a range of services, including care coordination, education, social work, and data collection, with the goal of improving health outcomes for those with sickle cell disease.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 09/15/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...